凯鹏华盈（Kleiner Perkins Caufield & Byers）第十五支早期风投基金已成功筹集资金5.25亿美元，进入封闭期。

    从很多方面来看，这支基金延续了凯鹏华盈一贯的传统：投资有望成为下一个谷歌（Google）或Genentech的新兴初创企业。但从10名“主管合伙人”团队来看，也出现了一些细微的差别。

    根据《财富》杂志（Fortune）此前报道，布鲁克•拜尔斯、雷•莱茵和比尔•乔伊已减少了投资活动（尽管他们可能会继续进行交易）。新基金的合伙人是：迈克•艾伯特、钱智华、阿莫尔•德什潘德、约翰•杜尔、宾•高登、谢文暄、兰迪•科米萨尔、马特•默菲、贝思•赛登伯格和特德•希莱恩。

    这10个人当中只有一人（赛登伯格）专注于生命科学投资，两人（德什潘德和谢文暄）专注于绿色科技，反映了凯鹏华盈15（KBCP XV）基金将大部分资金投入数字领域的计划。上一支早期基金——一支6.50亿美元的基金于去年初封闭——当初计划将约一半的资金投入数字领域，其余分别投资于生命科学和绿色科技。

    “这并不是我们不相信生命科学或绿色科技，”领导凯鹏华盈数字业务的特德•希莱恩说。“只是反映了我们认为在这个特定时期，最佳的投资机会在什么领域。”

    他补充说，凯鹏华盈有一支5亿多美元的绿色成长基金仍在对外投资，另外还有一支10亿美元的数字成长基金（由玛丽•米克尔主管）和一支投资社交科技公司的小型附属基金。

    凯鹏华盈15基金已开始进行投资。和该公司过去发行的基金一样，凯鹏华盈15依然按照以前的优先回报率面向有限合伙人售出。

    Facebook热闹上市之际，值得一提的是凯鹏华盈的确投资了Facebook，但去年3,800万美元的投资额相比彼时Facebook公司520亿美元的估值来说实在太小了（事实上，Facebook的IPO文件中都找不到凯鹏华盈的名字）。以当今估值计，这项投资的回报率约2倍，但这被很多人视为是“招牌交易”（poster transaction），也就是说，交易的主要目的是在公司的投资组合中增加一个赫赫有名的名字。

    译者：早稻米

    Kleiner Perkins Caufield & Byers has closed its fifteenth early-stage venture capital fund with $525 million in capital commitments.

    In many ways, this is just more of the same for Kleiner Perkins: Investing in young startups that it hopes will become the next Google (GOOG) or Genentech. But there also are some subtle differences, as reflected by the group of ten investment professionals listed as "managing members."

    As previously reported by Fortune, Brook Byers, Ray Lane and Bill Joy have scaled back their activities (although they may continue to do deals). The new fund's partners are: Mike Abbott, Chi-Hua Chien, Amol Deshpande, John Doerr, Bing Gordon, Wen Hsieh, Randy Komisar, Matt Murphy, Beth Seidenberg, and Ted Schlein.

    Of this decuplet, only one member (Seidenberg) is focused on life sciences investing. And just two (Deshpande and Hsieh) are focused on greentech. Its reflective of the firm's plan to invest the majority of KBCP XV into digital companies, whereas its prior early-stage fund -- a $650 million vehicle closed early last year -- was designed to invest around half of its money into digital, with teh remainder split between life sciences and greentech.

    "It's not about us not believing in life sciences or greentech," says Ted Schlein, who leads the firm's digital practice. "It's just a reflection on where we feel the best opportunities are at this particular time."

    He adds that the firm continues to invest out of a $500 million-plus green growth fund. It also has a $1 billion digital growth fund (led by Mary Meeker), and a small side fund for social technology investments.

    Kleiner Perkins already has begun making commitments out of KBCP XV, which was sold to limited partners with the same premium terms as its predecessor.

    And, given today's big news, it's worth noting that Kleiner Perkins did make an investment in Facebook (FB), but it was a relatively miniscule $38 million deal last year at a $52 billion valuation (so small, in fact, that Kleiner Perkins isn't mentioned in Facebook's IPO documents). The transaction would produce around a 2x return at today's valuation, but was viewed by many as a "poster transaction" -- or a deal designed primarily to add a popular name to the firm's portfolio.